Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
54.43
-2.20 (-3.88%)
At close: Nov 20, 2026, 4:00 PM EST
54.30
-0.13 (-0.24%)
After-hours: Nov 20, 2026, 7:57 PM EST
Liquidia Market Cap
Liquidia has a market cap or net worth of $4.9 billion as of November 20, 2026. It is the 3,477th most valuable company in the world and the 1,126th biggest in the United States. Its market cap has increased by 90.21% in one year.
Market Cap
4.90B
Enterprise Value
4.68B
1-Year Change
90.21%
Global Rank
Country Rank
#1,126 United States
Category
ChartMarket Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.80M to $4.90B, an increase of 2,822.82%. That is a compound annual growth rate of 49.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 4.90B | 63.46% |
| Dec 31, 2025 | 3.00B | 201.47% |
| Dec 31, 2024 | 995.30M | 27.47% |
| Dec 29, 2023 | 780.80M | 90.07% |
| Dec 30, 2022 | 410.80M | 62.31% |
| Dec 31, 2021 | 253.10M | 127.20% |
| Dec 31, 2020 | 111.40M | 39.60% |
| Dec 31, 2019 | 79.80M | -76.20% |
| Dec 31, 2018 | 335.30M | 99.82% |
| Jul 26, 2018 (IPO) | 167.80M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alkermes | 7.55B |
| Kiniksa Pharmaceuticals International, | 7.38B |
| Amneal Pharmaceuticals | 7.36B |
| Lantheus Holdings | 6.68B |
| Supernus | 5.94B |
| Hims & Hers Health | 3.42B |
| Amylyx Pharmaceuticals | 3.35B |
| Xeris Biopharma Holdings | 3.10B |